Christina Cho MD

PubMed

• Five-Year Real-World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B-Cell Precursor Acute Lymphoblastic Leukemia.
  Marcos de Lima, Partow Kebriaei, Francesco Lanza, Christina Cho, Gizelle Popradi
  American Journal of Hematology. 2025-05-01
• Health-Related Values Discussions with Patients Undergoing Allogeneic and Autologous Stem Cell Transplant: Feasibility and Acceptability of an Early Primary Palliative...
  Abigail G Cohen, Christina Cho, Emily Patterson, Jessica Magaldi, Tara Doga
  Transplantation and Cellular Therapy. 2025-02-01
• 1 citations
  Comprehensive Review of Early and Late Toxicities in CAR T-Cell Therapy and Bispecific Antibody Treatments for Hematologic Malignancies.
  Ayrton Bangolo, Behzad Amoozgar, Charlene Mansour, Lili Zhang, Sarvarinder Gill
  Cancers. 2025-01-17

Abstracts/Posters

• Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell Transplantation
  Christina Cho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First RemissionClinically Relevant Abstract
  Christina Cho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on C... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018